137 related articles for article (PubMed ID: 10709091)
1. Alteration of beta-catenin expression in esophageal squamous-cell carcinoma.
Ninomiya I; Endo Y; Fushida S; Sasagawa T; Miyashita T; Fujimura T; Nishimura G; Tani T; Hashimoto T; Yagi M; Shimizu K; Ohta T; Yonemura Y; Inoue M; Sasaki T; Miwa K
Int J Cancer; 2000 Mar; 85(6):757-61. PubMed ID: 10709091
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic expression of E-cadherin and beta-Catenin correlated with LOH and hypermethylation of the APC gene in oral squamous cell carcinomas.
Gao S; Eiberg H; Krogdahl A; Liu CJ; Sørensen JA
J Oral Pathol Med; 2005 Feb; 34(2):116-9. PubMed ID: 15641992
[TBL] [Abstract][Full Text] [Related]
3. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
4. Adenomatous polyposis coli gene, beta-catenin, and E-cadherin expression in proximal and distal gastric cancers and precursor lesions: an immunohistochemical study using tissue microarrays.
Gulmann C; Grace A; Leader M; Butler D; Patchett S; Kay E
Appl Immunohistochem Mol Morphol; 2003 Sep; 11(3):230-7. PubMed ID: 12966349
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of cytoplasmic beta-catenin correlates with reduced expression of E-cadherin, but not with phosphorylated Akt in esophageal squamous cell carcinoma: immunohistochemical study.
Zhang G; Zhou X; Xue L; Quan L; Wang Y; Zhou C; Lu N; Wang Q; Zhu H; Xu N
Pathol Int; 2005 Jun; 55(6):310-7. PubMed ID: 15943787
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
Lin YC; Wu MY; Li DR; Wu XY; Zheng RM
World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite analysis of the APC gene and immunoexpression of E-cadherin, catenin, and tubulin in esophageal squamous cell carcinoma.
Nair KS; Naidoo R; Chetty R
Hum Pathol; 2006 Feb; 37(2):125-34. PubMed ID: 16426911
[TBL] [Abstract][Full Text] [Related]
8. Frequent accumulation of nuclear E-cadherin and alterations in the Wnt signaling pathway in esophageal squamous cell carcinomas.
Salahshor S; Naidoo R; Serra S; Shih W; Tsao MS; Chetty R; Woodgett JR
Mod Pathol; 2008 Mar; 21(3):271-81. PubMed ID: 18084253
[TBL] [Abstract][Full Text] [Related]
9. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours.
Clavel CE; Nollet F; Berx G; Tejpar S; Nawrocki-Raby B; Kaplan HH; van Roy FM; Birembaut PL
J Pathol; 2001 May; 194(1):20-6. PubMed ID: 11329137
[TBL] [Abstract][Full Text] [Related]
10. beta-catenin expression pattern in primary oesophageal squamous cell carcinoma. Relationship with clinicopathologic features and clinical outcome.
de Castro J; Gamallo C; Palacios J; Moreno-Bueno G; Rodríguez N; Feliu J; González-Barón M
Virchows Arch; 2000 Dec; 437(6):599-604. PubMed ID: 11193470
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic beta-catenin in esophageal cancers.
Kimura Y; Shiozaki H; Doki Y; Yamamoto M; Utsunomiya T; Kawanishi K; Fukuchi N; Inoue M; Tsujinaka T; Monden M
Int J Cancer; 1999 Apr; 84(2):174-8. PubMed ID: 10096251
[TBL] [Abstract][Full Text] [Related]
12. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma.
Sanders DS; Bruton R; Darnton SJ; Casson AG; Hanson I; Williams HK; Jankowski J
Int J Cancer; 1998 Dec; 79(6):573-9. PubMed ID: 9842964
[TBL] [Abstract][Full Text] [Related]
13. Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines.
Pierceall WE; Woodard AS; Morrow JS; Rimm D; Fearon ER
Oncogene; 1995 Oct; 11(7):1319-26. PubMed ID: 7478552
[TBL] [Abstract][Full Text] [Related]
14. Expression of E-cadherin, alpha-catenin, beta-catenin and plakoglobin in esophageal carcinomas and its prognostic significance: immunohistochemical analysis of 96 lesions.
Nakanishi Y; Ochiai A; Akimoto S; Kato H; Watanabe H; Tachimori Y; Yamamoto S; Hirohashi S
Oncology; 1997; 54(2):158-65. PubMed ID: 9075789
[TBL] [Abstract][Full Text] [Related]
15. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
16. Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis.
Zhao XJ; Li H; Chen H; Liu YX; Zhang LH; Liu SX; Feng QL
World J Gastroenterol; 2003 Feb; 9(2):225-32. PubMed ID: 12532436
[TBL] [Abstract][Full Text] [Related]
17. APC, beta-catenin, and E-cadherin and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Kisters N; van Engeland M; Dunselman GA; de Haan J; de Goeij AF; Groothuis PG
Int J Gynecol Cancer; 2004; 14(5):947-56. PubMed ID: 15361208
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant.
Rocha AS; Soares P; Seruca R; Máximo V; Matias-Guiu X; Cameselle-Teijeiro J; Sobrinho-Simões M
J Pathol; 2001 Jul; 194(3):358-66. PubMed ID: 11439369
[TBL] [Abstract][Full Text] [Related]
19. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.
Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M
Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
